image
Rhythm Pharmaceuticals, Inc. RYTM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 64.63
-2.64 %
$ 4.11 B
Market Cap
-14.45
P/E
BALANCE SHEET
392 M ASSETS
17.89%
Growth Rates
1Year 17.89%
3Years 5.98%
5Years 4.92%
7Years 14.53%
10Years 114.08%
228 M LIABILITIES
39.72%
Growth Rates
1Year 39.72%
3Years 71.21%
5Years 52.62%
7Years 64.63%
10Years 82.62%
21.7 M EQUITY
-87.20%
Growth Rates
1Year -87.20%
3Years -57.55%
5Years -40.07%
7Years -23.73%
10Years 51.26%
BALANCE SHEET DECOMPOSITION
Balance Sheet Rhythm Pharmaceuticals, Inc.
image
Current Assets 374 M
Cash & Short-Term Investments 321 M
Receivables 18.5 M
Other Current Assets 35.1 M
Non-Current Assets 18.1 M
Long-Term Investments 0
PP&E 4.11 M
Other Non-Current Assets 14 M
81.72 %4.72 %8.95 %3.56 %Total Assets$392.3m
Current Liabilities 116 M
Accounts Payable 12.3 M
Short-Term Debt 0
Other Current Liabilities 103 M
Non-Current Liabilities 112 M
Long-Term Debt 3.94 M
Other Non-Current Liabilities 108 M
5.41 %45.31 %47.54 %Total Liabilities$227.7m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 89.1 60.1 127.7 59.2 100.9 62.3 49.5 34.2 6.5 34.9 0.2 7.4 11.8
Short Term Investments 231.4 215.8 205.6 235.6 71.9 230.2 202.5 113.8 4.0 0 0 10.4 5.3
Receivables 18.5 14.9 6.2 1.0 0 0 0 0 0 0 0 0 0
Inventory 18.7 8.6 2.9 0.1 0 0 0 0 0 0 0 0 0
Other Current Assets 16.4 8.9 11.8 12.4 8.9 9.9 6.6 2.6 0.6 0.6 42 K 0.4 1.8
Total Current Assets 374.2 308.3 354.2 308.4 181.7 302.4 258.7 150.7 11.2 35.5 0.2 18.1 18.9
PP&E 4.1 2.1 3.4 4.3 5.0 5.7 1.1 0.8 0.9 17 K 0 24 K 44 K
Intangible Assets 6.2 7.0 7.9 4.7 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0.3 0.3 0.4 0.4 0.4 0.2 0.2 0.3 0 0 0
Other Long Term Assets 7.8 15.3 17.0 12.1 0 0 0 0 9 K 1.5 0 23 K 23 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 392.3 332.7 382.5 329.5 187.1 308.5 260.2 151.7 12.3 37.3 0.2 18.2 18.9
LIABILITIES
Accounts Payable 12.3 4.9 4.8 5.7 4.9 10.4 7.6 2.4 1.9 1.4 0.5 1.5 2.2
Short Term Debt 0 0.8 1.4 1.2 1.1 0.9 0 0 0 0 0 0 0
Other Current Liabilities 101.9 48.3 32.2 29.5 12.0 13.1 5.9 4.3 2.8 3.6 17 K 1.6 0.3
Total Current Liabilities 115.5 55.2 39.8 43.4 18.0 24.4 13.6 6.7 4.7 5.3 0.6 3.1 2.5
Long Term Debt 3.9 0.5 1.3 1.9 2.6 3.1 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 108.3 107.3 77.2 0 0 0 0.4 0.2 0.3 0 0 72.6 52.7
Total Liabilities 227.7 163.0 118.2 45.4 20.5 27.5 14.0 6.9 5.0 5.3 0.6 75.6 55.2
EQUITY
Common Stock 61 K 59 K 56 K 50 K 44 K 44 K 34 K 27 K 10 K 10 K 93 K 53 K 3 K
Retained Earnings (1 155.3) (894.7) (710.1) (528.9) (459.3) (325.3) (184.6) (110.3) (76.5) (50.7) (39.6) (58.4) (37.0)
Other Accumulative Comprehensive Income/Loss 39 K 0.1 92 K 1 K 49 K 0 (0.8) (0.4) (0.1) 0 0 46 K 26 K
Total Equity 21.7 169.8 264.3 284.2 166.5 281.0 246.3 144.8 7.3 32.0 (0.4) (57.5) (36.3)
Total Liabilities and Equity 392.3 332.7 382.5 329.5 187.1 308.5 260.2 151.7 12.3 37.3 0.2 18.2 18.9
SHARES OUTSTANDING
Common Shares Outstanding 61.0 57.7 52.1 49.6 44.1 36.4 31.0 13.3 16.7 16.7 10.2 50.3 50.3